Synapse - Hematology-Oncology Fellows

Results (1422)

Outcomes with HMA plus venetoclax vs intensive chemotherapy in AML patients with chromosome 5 and 7 abnormalities

Meeting Abstract

Boussi, L.; Bewersdorf, J. P.; Liu, Y.; Shallis, R. M.; Aguirre, L. E.; Zucenka, A.; Garciaz, S.; Bystrom, R. P.; DeAngelo, D. J.; Stone, R. M.; more...
Blood (2024)

Fulltext@MSK | Save

Comparative analysis of outcomes with HMA plus venetoclax vs intensive chemotherapy in AML patients harboring very-high risk cytogenetics

Meeting Abstract

Aguirre, L. E.; Bewersdorf, J. P.; Liu, Y.; Shallis, R. M.; Boussi, L.; Zucenka, A.; Garciaz, S.; Bystrom, R. P.; Deangelo, D. J.; Stone, R. M.; more...
Blood (2024)

Fulltext@MSK | Save

Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with relapsed or refractory, splicing factor-mutant myeloid malignancies

Meeting Abstract

Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A. T.; Sallman, D.; Patel, M.; Stevens, D. A.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
Blood (2024)

Fulltext@MSK | Save

Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction

Meeting Abstract

Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
Blood (2024)

Fulltext@MSK | Save

Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
Blood (2024)

Fulltext@MSK | Save

Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience

Meeting Abstract

Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
Blood (2024)

Fulltext@MSK | Save

Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study

Meeting Abstract

Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
Blood (2024)

Fulltext@MSK | Save

Leukemiaphysician's perspective on transplant in patients with TP53 mutated acute myeloid leukemia

Meeting Abstract

Vanegas, Y. A. M.; El Khatib, S. Y. M.; Hisrich, B.; Coltoff, A.; Shallis, R. M.; Patel, A. A.; Bewersdorf, J. P.; Oh, T. S.; Abaza, Y.; Foucar, C.; more...
Blood (2024)

Fulltext@MSK | Save

Single-cell spatial transcriptomics identifies lymphoid aggregates with location-specific alterations of adaptive immune cells in human MDS bone marrow

Meeting Abstract

Stanley, R.; Zhang, B.; Argyropoulos, K.; Gipson, B.; Weis, K.; Lewis, A. M.; Katsamakis, Z.; Zhao, K.; Snopkowski, C.; Zatzman, M.; more...
Blood (2024)

Fulltext@MSK | Save

Efficacy and safety of brexucabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukemia in patients aged 60 and above

Meeting Abstract

Muhsen, I.; Advani, A. S.; Roloff, G. W.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Grunwald, M. R.; Kota, V. K.; Boccucci, J.; more...
Blood (2024)

Fulltext@MSK | Save